04.23.2024 - By ReachMD
CME credits: 1.00
Valid until: 23-04-2025
Claim your CME credit at https://reachmd.com/programs/cme/shhgene-silencing-therapies-for-attrv-pn/24137/
Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.